ACTIVE

APOTHEEK MEERDAAL

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result171,3 k €+77,1 %over 1 year

Gross margin300,4 k €+32,4 %over 1 year

Equity800,2 k €+2,7 %over 1 year

Workforce1,0 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK MEERDAAL is a Public limited company incorporated in 1988. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Oud-Heverlee. It employs on average 1,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0436.782.387
Incorporation: 30/12/1988
Legal form: Public limited company
Registered office: Bierbeekstraat 2B box 1
3052 Oud-Heverlee · FlandreSee on map
Contributed capital: 195 000,00 €
Latest accounts: 31/12/2025
Average workforce: 1,0 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	300,4 k €	+32.4%	226,9 k €	-0.1%	227,2 k €	+11.5%	203,9 k €	-41.4%	347,9 k €
EBITDA	240,1 k €	+41.5%	169,8 k €	-1.2%	171,9 k €	+6.9%	160,7 k €	-53.6%	346,6 k €
Operating result	194,4 k €	+59.4%	122 k €	-1.3%	123,6 k €	+6.4%	116,2 k €	-64.1%	323,8 k €
Net result	171,3 k €	+77.1%	96,8 k €	-6.9%	103,9 k €	-0.5%	104,4 k €	-54.0%	227,1 k €
Balance sheet
Equity	800,2 k €	+2.7%	778,9 k €	+2.9%	757,1 k €	+12.5%	673,2 k €	+18.4%	568,8 k €
Total assets	1,5 M €	+5.5%	1,4 M €	+6.9%	1,3 M €	+3.3%	1,3 M €	+48.5%	877 k €
Cash	209 k €	+87.6%	111,4 k €	+33.7%	83,3 k €	-41.8%	143,2 k €	+69.7%	84,4 k €
Debts	633,9 k €	+10.7%	572,3 k €	+14.8%	498,3 k €	-7.3%	537,5 k €	+149%	215,6 k €
Other
Workforce	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	+233%	0,3 ETP		–

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 18 ended

Active mandates

Fré Pharma

Director · 0849.038.129

Represented by Fréderic Hertens

Active

Ended mandates

Collin Ghislain

Director · since 01 janvier 2023 · until 20 décembre 2023

Ended

Fré Pharma

Managing director · since 05 juin 2018 · until 05 juin 2024 · 0849.038.129

Represented by Fréderic Hertens

Ended

Ghislain Collin

Director · since 05 juin 2018 · until 05 juin 2024

Ended

Fré Pharma

Managing director · since 01 octobre 2012 · until 01 octobre 2018 · 0849.038.129

Represented by Fréderic Hertens

Ended

Other companies at this address

Bierbeekstraat 2B 3052 Oud-Heverlee

Company	CBE no.
Dokter Marijke Vanderstappen● Active	0721.463.135
Fré Pharma● Active	0849.038.129

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	11/06/2026	28/08/2025	30/08/2024	31/08/2023	25/08/2022	30/08/2021
General meeting	01/06/2026	02/06/2025	03/06/2024	05/06/2023	06/06/2022	07/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	01/06/2026	11/06/2026	Dutch	PDF
Abridged model	31/12/2024	02/06/2025	28/08/2025	Dutch	PDF
Abridged model	31/12/2023	03/06/2024	30/08/2024	Dutch	PDF
Abridged model	31/12/2022	05/06/2023	31/08/2023	Dutch	PDF
Abridged model	31/12/2021	06/06/2022	25/08/2022	Dutch	PDF
Abridged model	31/12/2020	07/06/2021	30/08/2021	Dutch	PDF
Abridged model	31/12/2019	08/09/2020	25/09/2020	Dutch	PDF
Abridged model	31/12/2018	03/06/2019	19/08/2019	Dutch	PDF
Abridged model	31/12/2017	25/06/2018	10/08/2018	Dutch	PDF
Abridged model	31/12/2016	27/06/2017	27/07/2017	Dutch	PDF
Abridged model	31/12/2015	06/06/2016	07/07/2016	Dutch	PDF
Abridged model	31/12/2014	22/06/2015	06/08/2015	Dutch	PDF
Abridged model	31/12/2013	23/06/2014	04/08/2014	Dutch	PDF
Abridged model	31/12/2012	03/06/2013	22/08/2013	Dutch	PDF
Abridged model	31/12/2011	04/06/2012	08/06/2012	Dutch	PDF
Abridged model	31/12/2010	06/06/2011	14/06/2011	Dutch	PDF
Abridged model	31/12/2009	07/06/2010	01/07/2010	Dutch	PDF
Abridged model	31/12/2008	02/06/2009	03/06/2009	Dutch	PDF
Abridged model	31/12/2007	02/06/2008	05/06/2008	Dutch	PDF
Abridged model	31/12/2006	04/06/2007	18/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 18 ended

Active mandates

Fré Pharma

Director · 0849.038.129

Represented by Fréderic Hertens

Active

Ended mandates

Collin Ghislain

Director · since 01 janvier 2023 · until 20 décembre 2023

Ended

Fré Pharma

Managing director · since 05 juin 2018 · until 05 juin 2024 · 0849.038.129

Represented by Fréderic Hertens

Ended

Ghislain Collin

Director · since 05 juin 2018 · until 05 juin 2024

Ended

Fré Pharma

Managing director · since 01 octobre 2012 · until 01 octobre 2018 · 0849.038.129

Represented by Fréderic Hertens

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates07/02/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF
Registered office11/04/2022
MAATSCHAPPELIJKE ZETEL
PDF
Mandates06/12/2018
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares30/10/2012
BENAMING - KAPITAAL - AANDELEN
PDF
Mandates18/10/2012
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/09/2010
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025171,3 k €↑
2024
Annual accounts 202496,8 k €↓
2023
Annual accounts 2023103,9 k €↓
2022
Annual accounts 2022104,4 k €↓
2021
Annual accounts 2021227,1 k €↑
2020
Annual accounts 202041,7 k €↓
2019
Annual accounts 201948,8 k €↓
2018
Annual accounts 201854,1 k €↑
2017
Annual accounts 2017-13,9 k €↓
2016
Annual accounts 201694,9 k €↑
2015
Annual accounts 201529,3 k €↑
2014
Annual accounts 201423 k €↑
2013
Annual accounts 2013-21,8 k €↓
2012
Annual accounts 2012-1,2 k €↓
2011
Annual accounts 201189,7 k €↓
2010
Annual accounts 201091,3 k €↑
2009
Annual accounts 200973 k €↑
2008
Annual accounts 200847,4 k €↑
2007
Annual accounts 200738,1 k €↑
2006
Annual accounts 20068,3 k €
30/12/1988
IncorporationPublic limited company

APOTHEEK MEERDAAL

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline